Article info
PDFClinical science
Injection frequency and anatomic outcomes 1 year following conversion to aflibercept in patients with neovascular age-related macular degeneration
- Correspondence to Dr Thomas Hwang, Casey Eye Institute, 3375 SW Terwilliger Blvd, Portland, OR 97239, USA; hwangt{at}ohsu.edu
Citation
Injection frequency and anatomic outcomes 1 year following conversion to aflibercept in patients with neovascular age-related macular degeneration
Publication history
- Received December 24, 2013
- Revised March 13, 2014
- Accepted April 4, 2014
- First published May 2, 2014.
Online issue publication
February 10, 2017
Article Versions
- Previous version (22 March 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions